| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7263e6700b65944c0bae83de0d9e3c2d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-602
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-604
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-0004 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-148
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-92 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-92 |
| filingDate |
2008-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7f15a7c5db1a42c5d9584498bf00c50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ee6b99d9d9283285f854a10a10237d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6f6834b02b9e194959f4b7aec414d50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_353dcf61ff89ba176b12ab67a1093372
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5af117055599554fdcbf30aa54129b85 |
| publicationDate |
2009-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-102008002395-A1 |
| titleOfInvention |
Drug-loaded implant |
| abstract |
The invention relates to an active substance-loaded implant (100) having a carrier body (10) and at least one active substance (50) for release in a release area. The active substance (50) is intended for cancer therapy and / or palliative treatment and can be released in the intended state of action of the implant (100) in a body of a living organism locally and / or regionally controlled at a predeterminable rate and / or over a predefinable period of time. |
| priorityDate |
2008-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |